Download PDF Introduction The Consumer Healthcare sector has long been crucial for consumers to find quick solutions without heading to the doctors, covering over the counter (OTC) products such as supplements, medicines (painkillers), skincare, hygiene products, and more. With the rise of digital healthcare tools and prescription management, Consumer Healthcare Read more…
Download PDF Johnson & Johnson and its Competitors Johnson & Johnson (J&J) [NYSE: JNJ] is a US-based multinational healthcare corporation operating along its two segments Innovative Medicine and MedTech. Today (as of April 18th, 2024), the firm has a market capitalization of $351.2bn. In 2023, J&J recorded revenues of $85.2bn, Read more…
Download PDF Introduction Every course of Management or Business Administration covers organizational structure, simply because it is the cornerstone of every company. Some firms are very specialized and have well-established chains of command, therefore do not require an elaborate system of structures. Others have so complex and expansive activities that Read more…
Download PDF Introduction The pharmaceuticals sector has been the center of attention lately for the successful vaccines trial that finally gave some hope of recovery, even though it wasn’t without controversies. However, a lot more has been going on in the industry that might change the reputation that the industry Read more…
Johnson & Johnson (NYSE: JNJ) — market cap as of 10/02/2017: $310.36bn Actelion (VTX: ATLN) – market cap as of 10/02/2017: CHF 28.13bn Introduction On the January 26, 2017, the US healthcare behemoth Johnson & Johnson announced the acquisition of the Swiss biotech company Actelion for $30bn in cash. Read more…
Luxottica Group S.p.A. (BIT: LUX) — market cap as of 10/02/2016: €24.15bn Essilor International SA (EPA: EI) — market cap as of 10/02/2016: €23.72bn Introduction On January 16, 2017, Italy-based eyewear leader Luxottica SpA and French lensmaker Essilor International SA announced one of the largest cross-border mergers ever in Europe. Read more…
AbbVie Inc.; market cap (as of 06/03/2015): $88.7bn Pharmacyclics Inc.; market cap (as of 06/03/2015): $19.3bn Introduction On March 4, the pharmaceutical company AbbVie, outbidding the competitor Johnson & Johnson, agreed to buy the cancer biotech company Pharmacyclics in a $21bn transaction. The Chicago based company will pay $261.25 per Read more…
Apple, Inc. Market Cap (as of 03/05/13): $418.2 bn Transaction Size: $17.0bn On the 30th of April Apple Inc. has set a new corporate record. In fact, after having recently regained its position as the world’s most valuable company and having announced the largest share buyback in history, it sold $17bn of Read more…